Japan· JP-1119702G1062
セボフルラン
A sevoflurane product containing セボフルラン, registered in Japan by 丸石製薬, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Sevoflurane is registered in 17 of 19 countries.
Countries holding a registration under ATC N01AB08 (sevoflurane), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Sevoflurane · ATC N01AB08
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- セボフルラン
- Manufacturer
- 丸石製薬
- Country
- Japan (JP)
- ATC code
- N01AB08
- ATC class
- Sevoflurane
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
218 interactions on record for sevoflurane.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sevoflurane · interactions on record
218 records
- 42 severe
- 127 moderate
- 2 minor
- 47 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EpinephrineB02BC09severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N01AB08
Sevoflurane, as other registers publish it.
- NetherlandsSevofluraan Cadiasun 100%, vloeistof voor inhalatiedampCadiasun Pharma GmbH
- NetherlandsSevofluraan ELC 100%, vloeistof voor inhalatiedampELC Group s.r.o.
- DenmarkSevofluran "Baxter"Baxter A/S
- DenmarkSevofluran BaxterOrifarm A/S
- FinlandSevofluran BaxterBaxter Oy
- GermanySevofluran BaxterBaxter Deutschland Gmbh
- NorwaySevofluran BaxterBaxter Medical AB
- SwedenSevofluran Baxter 100 % Inhalationsånga, vätskaBaxter Medical AB
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f233b07e-2206-4afa-8e0e-82254f2f8023 GET /v1/drugs/f233b07e-2206-4afa-8e0e-82254f2f8023?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍＬ",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "1119702G1062",
"category": "外用薬",
"price_yen": 26.4,
"generic_name": "セボフルラン",
"product_name_jp": null,
"therapeutic_class": "1119",
"transitional_expiry": null
}See everything about sevoflurane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.